The Hope Clinic of Emory University

Decatur, Georgia 30030-1705

4 studies enrolling now · 18 studies all time

What they study most

Avian Influenza, COVID-19, COVID-19 Immunisation, COVID-19 SARS-CoV-2 Infection, Clostridioides Difficile Associated Disease, Gonorrhoea, Immunisation, Influenza A Subtype H5N1 Infection, Influenza Immunisation, Monkeypox, Rabies, Rabies Immunisation

Studies at this site

• A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults — Recruiting now
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
• Durability of Vaccine Responses — Recruiting now
• A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older — Recruiting now
• Phase 2 Shigella Vaccine and Challenge — Completed
• Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults — Completed
• Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine — Completed
• COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial) — Completed
• Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults — Completed
• Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines — Completed
• Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States — Completed
• Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination — Completed
• Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly — Completed
• Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects — Completed
• Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults — Completed
• Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) — Completed
• ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 — Completed
• Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response — Completed